title: Should CMR Become the New Darling of Noninvasive Imaging for the Monitoring of Progression and Regression of Coronary Heart Disease?
authors.affiliation: CVPath Institute, Inc., Gaithersburg, Maryland.
authors.forename: Kazuyuki
authors.initials: K
authors.lastname: Yahagi
authors.affiliation: CVPath Institute, Inc., Gaithersburg, Maryland.
authors.forename: Michael
authors.initials: M
authors.lastname: Joner
authors.affiliation: CVPath Institute, Inc., Gaithersburg, Maryland. Electronic address: rvirmani@cvpath.org.
authors.forename: Renu
authors.initials: R
authors.lastname: Virmani
mesh_terms: D003324:Coronary Artery Disease; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D058226:Plaque, Atherosclerotic; D011804:Quinolines
chemical_list: D011804:Quinolines
keywords: cardiac magnetic resonance; coronary artery disease; high-intensity plaque; noninvasive imaging; statin; thin-cap fibroatheroma; vulnerable plaque